Pfizer and BioNTech COVID-19 Vaccine Adapted for LP.8.1 Variant Receives Positive CHMP Opinion in EU Read more
European Commission Approves DARZALEX as First Licensed Treatment for High-Risk Smouldering Multiple Myeloma Read more
Gefurulimab Shows Significant Improvement in Daily Function for gMG Patients in Phase III PREVAIL Trial Read more